$SCPH

According to Morgan Stanley, the cutoff date to tender your shares in the scPharma ($SCPH) acquisition is October 3rd, 3 days before the October 6th expiration date. Effectively, your options are to tender and receive $5.35 in cash plus the contingent value right (CVR) I’ve written about and explained in previous posts….or…..to sell your shares … Read more

MannKind has announced the tender date for scPharma is October 6th, 2025. If you want to own the contingent value right (CVR), you should keep your shares and tender them in the offer. If you don’t want to own the CVR, then you should sell your shares prior to October 6th.   The documents filed … Read more

At DKI, we’ve been making an effort to be more transparent in how we make investment decisions and to provide more educational content. There are several interesting lessons which can be extracted from the recent scPharma takeover announcement. Before we dive in, I want to be clear that while a likely acquisition was a key … Read more

MannKind is acquiring DKI portfolio position scPharmaceuticals ($SCPH) for $5.35/share in cash plus a contingent value right (CVR) worth up to $1.00/share. The full value represents a 31% premium to Friday’s closing price. MannKind has the necessary financing from Blackstone.   This is the second DKI healthcare device portfolio company acquired in the past two … Read more